Pharmaceuticals
Closed Special Notice Posted
- Solicitation number
- HT08520012211928
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Place of performance
- Jbsa Ft Sam Houston, Texas 78234, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Medical Readiness Contracting Office-West has issued a Special Notice to award a Firm-Fixed-Price sole source call order to Nephron Pharmaceuticals Corporation for Pharmaceuticals. The notice was published by the Department of the Army Medical Command, which is a Defense agency. The applicable NAICS code for this requirement is 325412 - Pharmaceutical Preparation Manufacturing, with a size standard of 1,300 employees.
The purpose of the Special Notice is to inform the public of the government's intent to award a sole source contract to Nephron Pharmaceuticals Corporation for the period of performance from 15 December 2024 to 31 March 2025. The statutory authority permitting other than full and open competition is FAR 13.106-1(b)(1), which allows for purchases not exceeding the simplified acquisition threshold when only one source is reasonably available. The contracting officer has determined that these circumstances deem only one source reasonably available. This is not a request for competitive proposals, and no requests for capability briefings or telephonic inquiries will be honored. The government will make the award on or about 15 December 2024, and the determination not to compete this proposed contract is solely within the discretion of the government.
Notice text
The Medical Readiness Contracting Office-West intends to award a Firm-Fixed-Price sole source call order to Nephron Pharmaceuticals Corporation for Pharmaceuticals. The period of performance will be 15 December 2024 – 31 March 2025.
The statutory authority permitting other than full and open competition is authority FAR 13.106-1(b)(1): For purchases not exceeding the simplified acquisition threshold (SAT), only one source reasonably available, urgency, exclusive licensing agreements, brand name, or industrial mobilization.
Award will be made on or about 15 December 2024. The applicable NAICS code for this requirement is 325412 – Pharmaceutical Preparation Manufacturing, and the size standard is 1,300 employees.
THIS IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. This is a notice of intent to award a sole source contract. The Contracting Officer determined that the circumstances of the contract action deem only one source reasonable available.
No requests for capability briefings will be honored as a result of this notice and any information provided will not be used as part of any subsequent solicitation requirement. No telephonic inquires will be honored. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Intent to award sole source - Compact Robotic Prescription Dispensing System - Tsaile Health Center | Indian Health Service | No set-aside | |
| Notice of Intent to Sole Source – CARDINAL HEALTH 414, LLC– radiopharmaceuticals | Office of Logisitics and Acquisition Operations | No set-aside | |
| Notice of Award Maintenance for Government owned BacT/ALERT 3D Equipment. | Medical Command | No set-aside | |
| Inhaled Nitric Oxide | Defense Health Agency | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity